NCT Number: NCT04750863
Evaluation of Adult Onset Still Disease Classification Criteria and Differential Diagnosis at Eighteen Months of Follow-up
Adult Onset Still Disease (AOSD) is an acquired inflammatory disease of unknown etiology, presenting with non specific symptoms. Its diagnosis rely on sets of criteria, i.e. Fautrel Criteria and Yamaguchi Criteria. However, differential diagnosis might appear during follow-up of patients. The aim of this study is to assess diagnostic performance of Fautral and Yamaguchi Criteria after 18 months of follow-up, and to describe differential diagnosis appearing during follow-up.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Study type
Observational
About this study
Adult Onset Still Disease (AOSD) is an acquired inflammatory disease of unknown etiology, presenting with non specific symptoms. Other conditions such as cancer, infection or other inflammatory disease might mimick its symptoms. Its diagnosis rely on sets of criteria, i.e. Fautrel Criteria and Yamaguchi Criteria. However, differential diagnosis might appear during follow-up after an initial diagnosis of AOSD. The aim of this study is to assess diagnostic performance of Fautral and Yamaguchi Criteria after 18 months of follow-up, and to describe differential diagnosis appearing during follow-up.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- adults
- with glycosylated ferritin dosage for suspected adult onset still disease
- with at least 18 month of follow-up
Exclusion criteria
- known infectious disease
- known cancer
- known active connective tissue disease or vasculitis
Treatment and study plan
Primary outcomes
-
diagnosis performance of Yamaguchi and Fautrel criteria at 18 months of follow-up
Time frame: after 18 months of follow-up
Sensitivity, Specificity, positive predictive value, negative predictive value
Secondary outcomes
-
description of differential diagnosis mimicking adult onset still disease
Time frame: after 18 months of follow-up
-
identifying factors associated with the occurence of a differential diagnosis during follow-up
Time frame: after 18 months of follow-up
Sponsors and collaborators
Lead sponsor
Central Hospital, Nancy, France
Other
Registry information
Acronym: AOSD-DIF
Important dates
- Study start
- 2010
- Primary completion
- 2021
- Study completion
- 2021
- First posted
- Feb 11, 2021
- Registry last updated
- Feb 11, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)
NCT03311854
Adult Onset Still Disease, Arthritis
Cincinnati, Ohio, United States
View Trial DetailsRheumatology Patient Registry and Biorepository
NCT04402086
Adult Onset Still Disease, Ankylosing Spondylitis
New Haven, Connecticut, United States
View Trial DetailsStudy of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD
NCT04717635
Adult Onset Still's Disease, Arthritis
Chiba, Japan
View Trial DetailsAssessment of Macrophage Activation syndromE in STill's Disease in Italy
NCT06992505
Arthritis, Arthritis, Juvenile
Milan, Italy
View Trial Details